We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $14.1B
1-Year Est. Return 30.11%
This Fund
S&P 500
This Quarter Est. Return
+16.52%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$12B
AUM Growth
+$1.63B
Cap. Flow
+$315M
Cap. Flow %
2.63%
Top 10 Hldgs %
39.3%
Holding
1,552
New
107
Increased
840
Reduced
559
Closed
44

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.1M
2
MSFT icon
Microsoft
MSFT
+$34.8M
3
NVDA icon
NVIDIA
NVDA
+$33.9M
4
ABBV icon
AbbVie
ABBV
+$20M
5
GE icon
GE Aerospace
GE
+$19.3M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.3M
2
AMZN icon
Amazon
AMZN
+$19.9M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$17.7M
4
CRM icon
Salesforce
CRM
+$15.8M
5
MRK icon
Merck
MRK
+$15.6M

Sector Composition

Rank Sector Weight
1 Technology 37.48%
2 Financials 11.87%
3 Consumer Discretionary 11.39%
4 Communication Services 10.18%
5 Healthcare 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDS icon
1176
Telephone and Data Systems
TDS
$3.83B
$274K ﹤0.01%
7,687
+202
+3% +$7.09K
CIVI
1177
DELISTED
Civitas Resources
CIVI
$272K ﹤0.01%
9,892
-3,470
-26% -$100K
SIG icon
1178
Signet Jewelers
SIG
$3.48B
$271K ﹤0.01%
+3,404
New +$226K
ADNT icon
1179
Adient
ADNT
$1.58B
$271K ﹤0.01%
13,902
-2,018
-13% -$29.8K
STEP icon
1180
StepStone Group
STEP
$3.32B
$270K ﹤0.01%
4,873
-175
-3% -$9.37K
RYTM icon
1181
Rhythm Pharmaceuticals
RYTM
$7.04B
$270K ﹤0.01%
4,272
-93
-2% -$5.69K
AMKR icon
1182
Amkor Technology
AMKR
$16.2B
$269K ﹤0.01%
12,822
-346
-3% -$6.38K
FUL icon
1183
H.B. Fuller
FUL
$2.96B
$267K ﹤0.01%
4,440
+71
+2% +$3.92K
AMAL icon
1184
Amalgamated Financial
AMAL
$1.45B
$267K ﹤0.01%
8,552
+164
+2% +$4.8K
WK icon
1185
Workiva
WK
$2.84B
$267K ﹤0.01%
3,896
+46
+1% +$3.16K
AMBA icon
1186
Ambarella
AMBA
$3.09B
$266K ﹤0.01%
+4,030
New +$214K
ESI icon
1187
Element Solutions
ESI
$9.33B
$266K ﹤0.01%
11,751
+222
+2% +$4.65K
SKT icon
1188
Tanger
SKT
$4.72B
$266K ﹤0.01%
8,691
+535
+7% +$16.4K
DORM icon
1189
Dorman Products
DORM
$3.95B
$265K ﹤0.01%
2,162
+196
+10% +$23.8K
KRYS icon
1190
Krystal Biotech
KRYS
$9.65B
$265K ﹤0.01%
1,929
+56
+3% +$8.22K
SWTX
1191
DELISTED
SpringWorks Therapeutics
SWTX
$265K ﹤0.01%
5,637
+452
+9% +$20.1K
SKY icon
1192
Champion Homes
SKY
$4.39B
$264K ﹤0.01%
4,210
+162
+4% +$12.6K
RNST icon
1193
Renasant Corp
RNST
$3.97B
$264K ﹤0.01%
+7,334
New +$245K
MGNI icon
1194
Magnite
MGNI
$2.57B
$263K ﹤0.01%
+10,919
New +$161K
MAN icon
1195
ManpowerGroup
MAN
$2.32B
$262K ﹤0.01%
6,488
+337
+5% +$14.7K
FBP icon
1196
First Bancorp
FBP
$4.4B
$262K ﹤0.01%
12,567
+376
+3% +$7.39K
ASH icon
1197
Ashland
ASH
$3.05B
$262K ﹤0.01%
5,203
-309
-6% -$15.7K
RGTI icon
1198
Rigetti Computing
RGTI
$4.94B
$261K ﹤0.01%
21,981
+7,621
+53% +$80.4K
SLNO
1199
DELISTED
Soleno Therapeutics
SLNO
$260K ﹤0.01%
+3,106
New +$232K
OLN icon
1200
Olin
OLN
$2.69B
$260K ﹤0.01%
12,918
-664
-5% -$13.8K

Similar funds

Xponance's Q2 2025 Portfolio in Review

As of Q2 2025, Xponance held 1,552 positions worth $12B, up 16% from $10.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance's Q2 2025 filing shows 107 new, 840 increased, 559 reduced and 44 closed positions. Its largest new stake was Restaurant Brands International: 34,535 shares worth $2.29M. The largest sale was Alphabet (Google) Class A, an estimated $20.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Xponance's largest Q2 2025 buy was Restaurant Brands International: 34,535 shares worth $2.29M.
  • Xponance added most to Apple in Q2 2025, an estimated $40.1M increase.
  • Xponance's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $20.3M.
  • Xponance fully exited Discover Financial Services in Q2 2025, selling an estimated $6.11M.
  • Xponance's ten largest holdings make up 39% of its $12B portfolio in Q2 2025.
  • Xponance opened 107 new positions and closed 44 in Q2 2025.
  • Xponance's portfolio value rose 16% quarter-over-quarter to $12B.

Based on Xponance's 13F filing for Q2 2025, filed 14 Aug 2025.